Israel Englander Global Blood Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $5.17 Million - $10.9 Million	159,673 Added 41.59%	543,632 $37 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $1.6 Million - $2.69 Million	71,916 Added 23.05%	383,959 $12.3 Million
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $1.09 Million - $1.51 Million	-42,547 Reduced 12.0%	312,043 $10.8 Million
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $6.9 Million - $11.2 Million	276,967 Added 356.81%	354,590 $10.4 Million
Q3 2021 Nov 15, 2021	SELL	$25.48 - $37.34 $7.21 Million - $10.6 Million	-282,824 Reduced 78.46%	77,623 $1.98 Million
Q1 2021 May 17, 2021	BUY	$38.94 - $50.85 $13.6 Million - $17.8 Million	349,977 Added 3342.66%	360,447 $14.7 Million
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $20.7 Million - $35.1 Million	-550,971 Reduced 98.14%	10,470 $453,000
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $13.3 Million - $18.8 Million	252,789 Added 81.9%	561,441 $31 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $14.7 Million - $24.6 Million	301,020 Added 3944.18%	308,652 $19.5 Million
Q1 2020 May 14, 2020	SELL	$41.72 - $87.2 $9.14 Million - $19.1 Million	-219,068 Reduced 96.63%	7,632 $390,000
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $8.86 Million - $15.9 Million	193,878 Added 590.7%	226,700 $18 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $393,910 - $503,006	8,686 Added 35.99%	32,822 $1.59 Million
Q2 2019 Aug 15, 2019	SELL	$52.6 - $63.29 $83.4 Million - $100 Million	-1,585,683 Reduced 98.5%	24,136 $1.27 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $77.3 Million - $93.1 Million	1,470,277 Added 1053.64%	1,609,819 $71.7 Million
Q1 2019 May 14, 2019	SELL	$39.99 - $53.48 $5.11 Million - $6.83 Million	-127,799 Reduced 47.8%	139,542 $7.39 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $4.37 Million - $6.46 Million	138,413 Added 107.36%	267,341 $11 Million
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $8.97 Million - $12.1 Million	-235,949 Reduced 64.67%	128,928 $4.9 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $9.09 Million - $11.8 Million	234,851 Added 180.62%	364,877 $16.5 Million
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $13.9 Million - $23.1 Million	-349,812 Reduced 72.9%	130,026 $6.28 Million
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $13.9 Million - $21.4 Million	469,323 Added 4463.37%	479,838 $18.9 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $263,926 - $326,490	10,515	10,515 $326,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account